Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sabbagh

Showing results (211-220 of 330) with videos related to

Pageof 33
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersDaryl Jones, Jo Vandercappellen, Leah Zullig, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 28, 2011
Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disordersJohn N Caviness, Charles H Adler, Joseph G Hentz, et al.
Current Alzheimer Research|January 27, 2017
Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled TrialBoris Decourt, Denise Drumm-Gurnee, Jeffrey Wilson, et al.
Alzheimer Disease and Associated Disorders|October 9, 2009
Correlation of clinical features with argyrophilic grains at autopsyMarwan N Sabbagh, Sonny S Sandhu, Martin R Farlow, et al.
Parkinsonism & Related Disorders|March 10, 2007
Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's diseaseJ N Caviness, J G Hentz, V G Evidente, et al.
Parkinsonism & Related Disorders|September 5, 2024
Resting-state EEG predicts cognitive decline in a neuropathologically diagnosed longitudinal community autopsied cohortAlexander Choi, Nan Zhang, Charles H Adler, et al.
Acta Neuropathologica|December 4, 2009
Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?Sun-Ah Choi, Virgilio Gerald Hilario Evidente, John N Caviness, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersMarwan N Sabbagh, Daryl Jones, Jo Vandercappellen, et al.
Open Access Journal of Clinical Trials|March 4, 2020
MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer's DiseaseBoris Decourt, Jeffrey Wilson, Aaron Ritter, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 6, 2023
Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panelMarwan N Sabbagh, Angela Taylor, Douglas Galasko, et al.
Pageof 33

Showing results (211-220 of 330) with videos related to

Sort By:
Pageof 33
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersDaryl Jones, Jo Vandercappellen, Leah Zullig, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|May 28, 2011
Incidental Lewy body disease: electrophysiological findings suggesting pre-clinical Lewy body disordersJohn N Caviness, Charles H Adler, Joseph G Hentz, et al.
Current Alzheimer Research|January 27, 2017
Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled TrialBoris Decourt, Denise Drumm-Gurnee, Jeffrey Wilson, et al.
Alzheimer Disease and Associated Disorders|October 9, 2009
Correlation of clinical features with argyrophilic grains at autopsyMarwan N Sabbagh, Sonny S Sandhu, Martin R Farlow, et al.
Parkinsonism & Related Disorders|March 10, 2007
Both early and late cognitive dysfunction affects the electroencephalogram in Parkinson's diseaseJ N Caviness, J G Hentz, V G Evidente, et al.
Parkinsonism & Related Disorders|September 5, 2024
Resting-state EEG predicts cognitive decline in a neuropathologically diagnosed longitudinal community autopsied cohortAlexander Choi, Nan Zhang, Charles H Adler, et al.
Acta Neuropathologica|December 4, 2009
Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?Sun-Ah Choi, Virgilio Gerald Hilario Evidente, John N Caviness, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersMarwan N Sabbagh, Daryl Jones, Jo Vandercappellen, et al.
Open Access Journal of Clinical Trials|March 4, 2020
MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer's DiseaseBoris Decourt, Jeffrey Wilson, Aaron Ritter, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 6, 2023
Listening session with the US Food and Drug Administration, Lewy Body Dementia Association, and an expert panelMarwan N Sabbagh, Angela Taylor, Douglas Galasko, et al.
Pageof 33